Humbert, Olivier
Laszlo, George S.
Sichel, Sophie
Ironside, Christina
Haworth, Kevin G.
Bates, Olivia M.
Beddoe, Mary E.
Carrillo, Ray R.
Kiem, Hans-Peter http://orcid.org/0000-0001-5949-4947
Walter, Roland B. http://orcid.org/0000-0002-9268-3341
Funding for this research was provided by:
Leukemia and Lymphoma Society (6489-16)
Article History
Received: 7 May 2018
Revised: 17 August 2018
Accepted: 10 September 2018
First Online: 5 October 2018
Compliance with ethical standards
:
: RBW has received laboratory research grants and/or clinical trial support from Actinium Pharmaceuticals, Inc, Amgen Inc., Amphivena Therapeutics, Inc., Covagen AG, and Seattle Genetics, Inc.; has ownership interests with Amphivena Therapeutics, Inc.; and is (or has been) a consultant to Amphivena Therapeutics, Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Covagen AG, Pfizer, Inc., and Seattle Genetics, Inc. H-PK is a consultant for Rocket Pharma and Homology Medicines. The other authors declare that they have no conflict of interest.